Abu Md Ashif Ikbal

Mr. Abu Md Ashif Ikbal

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SASyed Mohammed Basheeruddin Asdaq
Syed Mohammed Basheeruddin Asdaq
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
RSRam Kumar Sahu
Ram Kumar Sahu
BBBedanta Bhattacharjee
Bedanta Bhattacharjee
TPTirna Paul
Tirna Paul
Katharigatta VenugopalaKatharigatta Venugopala
Katharigatta Venugopala
The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight.

6 September 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
RSRam Kumar Sahu
Ram Kumar Sahu
MSMounir M. Salem-Bekhit
Mounir M. Salem-Bekhit
BBBedanta Bhattacharjee
Bedanta Bhattacharjee
YAYosif Almoshari
Yosif Almoshari
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
IEIbrahim Elbagory
Ibrahim Elbagory
Mucormycosis in patients who have COVID-19 or who are otherwise immunocompromised has become a global problem, causing significant morbidity and mortality. Infection is debilitating and fatal, leading to loss of organs and emotional trauma. Radiographic manifestations are not specific, but diagnosis can be made through microscopic examination of materials collected from necrotic lesions. Treatment requires multidisciplinary expertise, as the fungus enters through the eyes and nose and may even reach the brain. Use of the many antifungal drugs available is limited by considerations of resistance and toxicity, but nanoparticles can overcome such limitations by reducing toxicity and increasing bioavailability. The lipid formulation of amphotericin-B (liposomal Am-B) is the first-line treatment for mucormycosis in COVID-19 patients, but its high cost and low availability have prompted a shift toward surgery, so that surgical debridement to remove all necrotic lesions remains the hallmark of effective treatment of mucormycosis in COVID-19. This review highlights the pathogenesis, clinical manifestation, and management of mucormycosis in patients who have COVID-19.

22 March 2023 in International Nano Letters
Verified
Journal Article
Closed access
PDF file
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
ARAmlanjyoti Rajkhowa
Amlanjyoti Rajkhowa
WSWaikhom somraj singh
Waikhom somraj singh
KMKuntal Manna
Kuntal Manna

29 January 2025 in Polymers
Verified
Journal Article
Open access
PDF file
RDRabin Debnath
Rabin Debnath
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
NRNeeraj Kumar Ravi
Neeraj Kumar Ravi
HKHanieh Kargarzadeh
Hanieh Kargarzadeh
PPPartha Palit
Partha Palit
STSabu Thomas
Sabu Thomas
Carbon nanodots (CNDs) have garnered significant attention as viable drug delivery vehicles in recent years, especially in the field of phytomedicine. Although there is much promise for therapeutic applications with phytomedicine, its effectiveness is frequently restricted by its low solubility, stability, and bioavailability. This paper offers a thorough synopsis of the developing field of phytomedicine drug delivery based on CND. It explores CND synthesis processes, surface functionalization strategies, and structural and optical characteristics. Additionally, the advantages and difficulties of phytomedicine are examined, with a focus on the contribution of drug delivery methods to the increased effectiveness of phytomedicine. The applications of CNDs in drug delivery are also included in the review, along with the mechanisms that underlie their improved drug delivery capabilities. Additionally, it looks at controlled-release methods, stability augmentation, and phytomedicine-loading tactics onto CNDs. The potential of polymeric carbon nanodots in drug delivery is also covered, along with difficulties and prospective directions going forward, such as resolving toxicity and biocompatibility issues. In summary, the present review highlights the encouraging contribution of CNDs to the field of drug delivery, specifically in enhancing the potential of phytomedicine for therapeutic purposes.

1 February 2025 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PCParomita Dutta Choudhury
Paromita Dutta Choudhury
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
SSSourav Saha
Sourav Saha
RDRabin Debnath
Rabin Debnath
BDBIKASH DEBNATHY
BIKASH DEBNATHY
WSWaikhom somraj singh
Waikhom somraj singh
Rapid growth in nanotechnology, also known as 21st-century technology, is occurring in response to the increasing diversity of diseases. The development of safe and effective drug delivery methods to enhance bioavailability is of paramount importance. Researchers have focused on creating safe, cost-effective, and environmentally friendly nanoparticle construction processes. Natural polysaccharides, a type of multifaceted polymer with a wide range of applications and advantages, are particularly well suited for nanoparticle formulations, as they can mitigate the adverse consequences of synthetic nanoparticle formulations and promote sustainability. This review summarizes various sources of natural-based polysaccharides and polyacrylamide-based nanomaterials in nanoparticle preparation. Additionally, it discusses the use of natural polysaccharides in formulations beyond nanotechnology, highlighting their importance in green synthesis and different preparation methods.

1 January 2021 in Pharmaceutical and Biosciences Journal
Verified
Journal Article
Open access
BBBedanta Bhattacharjee
Bedanta Bhattacharjee
AIAbu Md Ashif Ikbal
Abu Md Ashif Ikbal
RSRam Kumar Sahu
Ram Kumar Sahu
MRMeenakshi Ratra
Meenakshi Ratra
The Coronavirus disease (COVID-19) is a worldwide pandemic caused by Severe acute respiratory syndrome 2 (SARS-CoV-2) which make an appearance in Wuhan China and spread globally. Coronavirus is a highly contagious virus, under the family Coronaviridae. SARS-CoV-2 causes respiratory breathing problems and can be transmitted through close contact, respiratory droplets and aerosol transmission. The binding of the structural spike proteins with the human ACE2 receptors plays a key role to initiate the event and severe complication of the disease. Clinical manifestation includes high fever, cough and dyspnoea. At present, there is no specific therapeutic strategy is available against the virus, only supportive care and management may be provided to the patients. In this review, we mainly focus and analyze the genetic morphology, pathogenesis and the therapeutic intervention. We further discuss the future perspective to confront with this viral epidemic.